Anti-drug antibody formation in Japanese Fabry patients following enzyme replacement therapy
Author:
Funder
JSPS KAKENHI
Publisher
Elsevier BV
Subject
Endocrinology,Genetics,Molecular Biology
Reference32 articles.
1. Fabry disease;Germain;Orphanet J. Rare Dis.,2010
2. Use of a rare disease registry for establishing phenotypic classification of previously unassigned GLA variants: a consensus classification system by a multispecialty Fabry disease genotype-phenotype workgroup;Germain;J. Med. Genet.,2020
3. X-chromosome inactivation in female patients with Fabry disease;Echevarria;Clin. Genet.,2016
4. Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease;Germain;J. Med. Genet.,2015
5. Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: a Fabry outcome survey analysis;Beck;Mol. Genet. Metab. Rep.,2015
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Reducing agalsidase beta infusion time in Fabry patients: low incidence of antibody formation and infusion-associated reactions in an Italian multicenter study;Orphanet Journal of Rare Diseases;2024-02-02
2. Profiles of Globotriaosylsphingosine Analogs and Globotriaosylceramide Isoforms Accumulated in Body Fluids from Various Phenotypic Fabry Patients;Internal Medicine;2024
3. Effects of switching from agalsidase−α to agalsidase−β on biomarkers, renal and cardiac parameters, and disease severity in fabry disease forming neutralizing antidrug antibodies: a case report;CEN Case Reports;2023-12-22
4. Monitoring of anti-drug antibodies and disease-specific biomarkers in three patients from a Japanese Fabry family treated with enzyme replacement therapy;CEN Case Reports;2022-10-07
5. Mechanisms of Neutralizing Anti-drug Antibody Formation and Clinical Relevance on Therapeutic Efficacy of Enzyme Replacement Therapies in Fabry Disease;Drugs;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3